Health News

(University of Central Florida) Two new compounds created by a University of Central Florida professor show early promise for destroying breast cancer tumors. Researchers have observed no negative side effects so far.

Read more

Filed under: General Health News
Tags: Breast Cancer, cancer, General Health News, Tumor

Related posts

• Zometa (zoledronic acid) shown to enhance chemotherapy in reducing breast tumor size (0)
  New data released demonstrates that the addition of Zometa (zoledronic acid) injection to standard chemotherapy before breast cancer surgery reduces the size of breast tumors more effectively than chemotherapy alone in women with early-stage disease. Read more [tags] General Health News [/tags]
  
  
• Therapy targeting cyclin D1 protein may block expansion of breast cancer cells (0)
  Breast cancer stem cells are known to be involved in therapy resistance and the recurrence of cancerous tumors. Read more [tags] General Health News [/tags]
  
  
• Therapy may block expansion of breast cancer cells (0)
  (Wiley-Blackwell) Breast cancer stem cells are known to be involved in therapy resistance and the recurrence of cancerous tumors. A new study appearing in Clinical and Translational Science shows the mechanisms governing stem cell expansion in breast cancer (called Notch activity), and finds that therapy targeting a protein called cyclin D1 may block the expansion [...]
  
  
• Study examines risk factors for cancer in unaffected breast of breast cancer patients (0)
  (American Cancer Society) A new study identifies certain patient and tumor characteristics that may help indicate which breast cancer patients would be the most likely to benefit from preventive surgery to remove the unaffected breast. Read more [tags] General Health News [/tags]
  
  
• Risk Factors Warranting Contralateral Prophylactic Mastectomy for Breast Cancer Identified (0)
  Risk factors that may warrant contralateral prophylactic mastectomy for breast cancer have been identified, such as a 5-year Gail risk of 1.67% or greater or an invasive lobular or multicentric tumor. Medscape Medical News Read more [tags] General Health News [/tags]